, little is known about the moleular pathogeness of the sporadic variants of the tumour. It has been shown that a number of phaeochromocytomas have loss of heterozygosity of chromosome 17p (Khosla et al., 1991) . The p53 tumour-suppressor gene, located on this region (17pl3), has been reported as the most frequent genetic abnormality seen in human malignancies (Hollstein et al., 1991) . This gene codes for a phosphoprotein that is involved in cell cycle regulation (Lane, 1993; Zambetti and Levine, 1993). Variations in the gene structure that lead to impaired function of the p53 protein may confer genetic instability to the cell, favouring the development of neoplasia (Hollstein et al., 1991) .
, little is known about the moleular pathogeness of the sporadic variants of the tumour. It has been shown that a number of phaeochromocytomas have loss of heterozygosity of chromosome 17p (Khosla et al., 1991) . The p53 tumour-suppressor gene, located on this region (17pl3), has been reported as the most frequent genetic abnormality seen in human malignancies (Hollstein et al., 1991) . This gene codes for a phosphoprotein that is involved in cell cycle regulation (Lane, 1993; Zambetti and Levine, 1993) . Variations in the gene structure that lead to impaired function of the p53 protein may confer genetic instability to the cell, favouring the development of neoplasia (Hollstein et al., 1991) .
With the aim of detrmining the potential role of p53 in this tumour, we have searched for mutations in a series of phaeochromocytomas using polymerase chain reactionsingle strand conformation polymorphism (PCR-SSCP) analysis of the 'hotspot' region of the gene; the expression of the p53 protein in tumour samples was also assessed by immunohistochemistry.
Materak and Patients
We studied 25 phaeochromocytomas, of which only one was non-functional. The patients' mean age was 31.4 years (range 9-64 years), with tumour size ranging from 4 to 11.5 cm (mean 7.2 cm). Four tumours were ectra-adrenal. Three of the tumours were hereditary, originatig from patients with neurofibromatosis, von Hippel-Lindau disease and familial phaeochromocytoma (without evidence of the complete multiple endocrine neoplasia 2A syndrome); the other 22 were sporadic forms. Twenty-one phaeochromocytomas were benign and four malignant. 
PCR-SSCP analysis

Results
No specific mutations were found in the DNA from any of the analysed samples (Figure 1) . A polymorphism was found in exon 4 (codon 72), identified by both SSCP conditions and restriction analysis with BstUI. Six samples contained a proline (CCC); five, an arginine (CGC). and the remaining 14 were heterozygous. containing both proline and arginine at this position (Figure 2 ).
A single sample showed overexpression of p53 protein in the immunohistochemical analysis. disclosing the expected nuclear staining pattern in more than 10% of the cells (Figure 3) 
Discussion
We found no mutations of the p53 gene in a representative population of phaeochromocytomas. The only abnormal sample in our study at immunohistochemistry was derived from a benign, sporadic, extraadrenal phaeochromocytoma. Although an increased potential for malignant development in extra-adrenal phaeochromocytomas has been suggested (Linnoila et al., 1990) , no metastases were found at surgery in this patient. Additionally, none of the four malignant phaeochromocytomas here studied showed molecular or immunohistochemical abnormalities.
Three other studies have attempted to explore a possible role for p53 in phaeochromocytomas (Yana et al., 1992; Yoshimoto et al., 1992; Lin et al., 1994) . These studies produced conflicting results: two of these had results similar to our own, as no abnormalities in this gene were found (Yana et al., 1992; Yoshimoto et al., 1992) . However, Lin et al. (1994) found an elevated frequency of p53 mutations, most of which were located in exon 4, in a small series of phaeochromocytomas. The analysis of the exon 4 in our tumours did not show mutations. The polymorphism found in codon 72 has already been reported (Matlashewski et al., 1987) and the allelic frequency observed in our samples did not differ from that previously descnrbed (Weston et al., 1992; Zhang et al., 1992) . Although the proline isoform of p53 protein was found to be twice as stable as the arginine variant in a cell line (Zhang et al., 1992) , and a relative overrepresentation of the proline isoform in lung adenocarcinomas has been described (Weston et al., 1992) , an attempt to associate a potential susceptibility with malignant phenotype conferred by any of the polymorphic variants has not been successful (Zhang et al., 1992) . Interestingly, our abnormal sample at immunohistochemistry contained a proline at codon 72. No preferential allele incidence was observed in our malignant samples.
The finding of immunohistochemical overexpression of p53 protein in a single sample not harbounrng mutation might result either from structural abnormalities outside the studied region or from abnormal stabilisation of the wild-type protein. leading to an increase in its half-life. The former condition occurs in less than 10% of various human tumours studied so far (Hollstein et al., 1991) . Moreover, mutations outside the 'hotspot' region are more commonly of the nonsense type. as opposed to the usual missense mutations that occur in the 'hotspot' region between exons 5 and 8 (Bodner et al., 1992) . These nonsense mutations are expected to form a truncated mutant protein. unable to react with p53 antibodies, in contrast with the p53 staining observed in our case. However, factors other than mutations may lead to p53 protein overexpression. These conditions are mostly related to stabilisation of the protein as a result of binding of p53 to cellular regulatory proteins, as mdm2 (Momand et al., 1992) .
Thus, based on our results, we conclude that mutations of the 'hotspot' region of p53 gene are unlikely to play an important role in the origin or development of phaeochromocytoma.
